Mafeng Chen
Overview
Explore the profile of Mafeng Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
45
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liang M, Zhang Z, Wu L, Chen M, Tan S, Huang J
Discov Oncol
. 2025 Feb;
16(1):117.
PMID: 39904937
Introduction: Patients with lung adenocarcinoma (LUAD) who develop brain metastases (BM) face significantly poor prognoses. A well-crafted prognostic model could greatly assist clinicians in patient counseling and in devising tailored...
2.
Liang M, Huang J, Liu C, Chen M
Cancer Invest
. 2024 Jul;
42(7):544-558.
PMID: 39007912
Typical Pulmonary Carcinoid (TPC) is defined by its slow growth, frequently necessitating surgical intervention. Despite this, the long-term outcomes following tumor resection are not well understood. This study examined the...
3.
Liang M, Chen M, Singh S, Singh S
Cancer Causes Control
. 2023 Oct;
35(3):465-475.
PMID: 37843701
Introduction: Brain metastasis (BM) is an aggressive complication with an extremely poor prognosis in patients with small-cell lung cancer (SCLC). A well-constructed prognostic model could help in providing timely survival...
4.
Liang M, Chen M, Singh S, Singh S
Sci Rep
. 2023 Sep;
13(1):14947.
PMID: 37696987
Small-cell lung cancer (SCLC) is an aggressive lung cancer subtype with an extremely poor prognosis. The 5-year survival rate for limited-stage (LS)-SCLC cancer is 10-13%, while the rate for extensive-stage...
5.
Liang M, Chen M, Singh S, Singh S, Zhou C
Clin Respir J
. 2023 Apr;
17(6):556-567.
PMID: 37118997
Introduction: Patients presenting with brain metastases (BMs) from lung squamous cell carcinoma (LUSC) often encounter an extremely poor prognosis. A well-developed prognostic model would assist physicians in patient counseling and...
6.
Liang M, Chen M, Singh S, Singh S
Adv Ther
. 2021 Nov;
39(1):346-359.
PMID: 34729705
Introduction: Small cell lung cancer (SCLC) is known for its rapid clinical progression and poor prognosis. In this study, we sought to establish a prognostic nomogram among SCLC patients who...
7.
Liang M, Chen M, Zhong Y, Singh S, Singh S
Front Genet
. 2021 Oct;
12:739520.
PMID: 34630529
Lung adenocarcinoma is one of the most common malignant tumors of the respiratory system, ranking first in morbidity and mortality among all cancers. This study aims to establish a ferroptosis-related...
8.
Liang M, Luo N, Chen M, Chen C, Singh S, Singh S, et al.
Infect Dis Ther
. 2021 May;
10(3):1267-1285.
PMID: 33939121
Introduction: The coronavirus disease 2019 (COVID-19) was defined as a species of beta coronavirus causing atypical respiratory disease in humans. The COVID-19 pandemic has resulted in an unprecedented health and...
9.
Luo N, Tan S, Li X, Liu S, Singh S, Chen M, et al.
BMC Infect Dis
. 2021 Jan;
21(1):8.
PMID: 33407179
Background: Nocardiosis is an uncommon opportunistic infection seen in immunocompromised patients or those with a dysfunctional immune system. Nocardia asteroides infection in patients with Pemphigus foliaceus (PF) has never been...
10.
Luo N, Tan S, Li X, Singh S, Liu S, Chen C, et al.
J Pain Symptom Manage
. 2020 Jul;
61(1):198-210.e1.
PMID: 32730950
Background: Dyspnea is one of the most distressing symptoms encountered by advanced cancer patients. In this study, we aimed to evaluate the role of opioids in the management of cancer-related...